Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Scandinavian Controlled, Randomized, Open-label, and Multi-centre Study Evaluating if Once-daily Tacrolimus or Twice-daily Cyclosporin, Reduces the 3-year Incidence of Chronic Lung Allograft Dysfunction After Lung Transplantation

NCT02936505 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT02936505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02936505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Scandinavian Controlled, Randomized, Open-label, and Multi-centre Study Evaluating if Once-daily Tacrolimus or Twice-daily Cyclosporin, Reduces the 3-year Incidence of Chronic Lung Allograft Dysfunction After Lung Transplantation
Lead sponsor
Vastra Gotaland Region
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 12, 2016
Completion date
October 30, 2026
Enrollment
249 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

allografts, lung transplantation